Chile Launches Early 2026 Vaccination Campaign, Prioritizing Influenza, COVID-19, and RSV
Santiago, Chile – On March 1, 2026, Chile’s Ministry of Health (MINSAL) initiated its 2026 vaccination and immunization campaign, marking the second consecutive year the campaign has been launched ahead of the typical winter season. This proactive approach aims to better prepare the population for the increased respiratory illnesses expected during the colder months. The campaign will focus on providing vaccinations against influenza, COVID-19, and, for the first time as part of a national program, respiratory syncytial virus (RSV). This comprehensive strategy underscores Chile’s longstanding commitment to public health and preventative medicine.
The early start to the vaccination drive reflects a growing understanding of the importance of proactive public health measures in mitigating the impact of seasonal viruses. Chile has a well-established history of successful vaccination programs, and this year’s campaign builds upon that foundation. The inclusion of RSV vaccination is a particularly significant development, as the virus poses a serious threat to infants and older adults. According to the Pan American Health Organization (PAHO), RSV is a leading cause of lower respiratory tract infections in young children and can also cause severe illness in vulnerable older populations. PAHO plays a crucial role in supporting countries in the Americas in strengthening their immunization programs.
During the inauguration of the campaign, Chile’s Minister of Health, Dr. Ximena Aguilera, stated, “We are the first country in the Southern Hemisphere to launch its immunization campaign, with the conviction that prevention is the noblest of duties of the State towards its citizens.” She further emphasized that this practice embodies “a republican tradition of decades, in which the State has placed the health of the population at the center of public policies.” This statement highlights the Chilean government’s prioritization of public health as a fundamental responsibility and a cornerstone of its governance.
A Tradition of Immunization and Public Health Leadership
Dr. Aguilera underscored that vaccination is “a tradition of which we must be proud,” recalling Chile’s long history of commitment to public health. “From the eradication of diseases that affected entire generations to becoming a world reference in vaccination, Chile has demonstrated that immunization is a state policy, not a government policy.” This assertion is supported by Chile’s consistent high rates of vaccination coverage and its success in eliminating or controlling several infectious diseases. The country’s robust vaccination infrastructure and public trust in health authorities have been key factors in its achievements.
Chile’s commitment to vaccination extends beyond routine childhood immunizations. The country has been a leader in introducing modern vaccines and implementing innovative vaccination strategies. For example, Chile was among the first countries in Latin America to introduce the human papillomavirus (HPV) vaccine into its national immunization program. This proactive approach has contributed to a significant reduction in HPV-related cancers and precancerous lesions.
PAHO/WHO Support and Regional Implications
Representing the Pan American Health Organization/World Health Organization (PAHO/WHO), Olivia Brathwaite, advisor to the Office in Chile, praised the country’s decision to anticipate and prepare the population, placing people at the center and reinforcing preventative actions. “This campaign represents a deep commitment to public health and equity,” she affirmed. The support from PAHO/WHO underscores the importance of international collaboration in strengthening immunization programs and addressing public health challenges.
Brathwaite added that Chile’s experience – and the lessons from the region – remind us that preparation saves lives: “A well-coordinated campaign reduces hospitalizations, avoids serious complications, and protects the continuity of health services. It also strengthens citizen confidence and reinforces the country’s resilience to health challenges.” This statement highlights the broader implications of Chile’s proactive approach for other countries in the region. Sharing best practices and lessons learned is crucial for improving public health outcomes across the Americas.
Focus on Influenza, COVID-19, and RSV Vaccination
The 2026 vaccination campaign will prioritize the inoculation of the population requiring protection against influenza and COVID-19. The inclusion of the RSV vaccine is a significant expansion of the program, particularly given the vulnerability of infants and older adults to severe RSV infection. RSV can cause bronchiolitis and pneumonia, leading to hospitalization and, in some cases, death. The Centers for Disease Control and Prevention (CDC) estimates that RSV causes approximately 60,000-160,000 hospitalizations and 6,000-10,000 deaths annually in the United States among older adults and young children. CDC provides comprehensive information on RSV, including prevention and treatment.
The specific target groups for each vaccine will be determined by MINSAL based on the latest epidemiological data and recommendations from health authorities. Typically, influenza and COVID-19 vaccines are recommended for high-risk groups, including older adults, individuals with underlying medical conditions, and healthcare workers. The RSV vaccine is expected to be prioritized for infants and older adults, as these groups are most vulnerable to severe illness.
Challenges and Considerations for the Campaign
While Chile has a strong track record of successful vaccination campaigns, several challenges and considerations will be crucial for the success of the 2026 campaign. Maintaining high vaccination coverage rates requires ongoing efforts to address vaccine hesitancy and ensure equitable access to vaccines. Effective communication strategies are essential for building public trust and dispelling misinformation about vaccines. Logistical challenges related to vaccine distribution and administration must be addressed to ensure that vaccines reach all segments of the population.
The ongoing evolution of the COVID-19 virus also presents a challenge. The emergence of new variants may require adjustments to the vaccine composition to maintain optimal protection. Continuous monitoring of viral strains and adaptation of vaccination strategies will be essential for staying ahead of the pandemic. The World Health Organization (WHO) provides regular updates on the latest COVID-19 variants and vaccine recommendations. WHO is a leading source of information on the global COVID-19 pandemic.
Looking Ahead: Strengthening Public Health Resilience
Chile’s proactive approach to vaccination and immunization demonstrates its commitment to strengthening public health resilience. By anticipating and preparing for seasonal viruses, the country is taking steps to protect its population and minimize the impact of future health crises. The success of the 2026 vaccination campaign will depend on continued collaboration between MINSAL, PAHO/WHO, and other stakeholders, as well as ongoing efforts to build public trust and ensure equitable access to vaccines.
The lessons learned from Chile’s experience can inform vaccination strategies in other countries in the region and around the world. Investing in robust vaccination programs and strengthening public health infrastructure are essential for protecting populations from infectious diseases and building a healthier future. The next key update from MINSAL regarding the campaign’s progress is expected in April 2026, when preliminary coverage rates will be released. Readers are encouraged to share their thoughts and experiences with vaccination in the comments below.